Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
for T-cell Acute Lymphoblastic Leukemia
16 locations incl. Phoeniz
Sponsor: New York Medical College
Sex: All·Age: Up to 39
Code: NCT04972942·Phase 1·Recruiting·Listed Jul 2021